戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (right1)

通し番号をクリックするとPubMedの該当ページを表示します
1                                          No vaccine-related serious adverse effects were found in the dose-ranging study
2 group and 7 (2.4%) in the control group reported at least 1 serious adverse event (adjusted RR, 1.72 [95% CI, 0.7 to 4.3]
3  or due to adverse events (OR 2.65, 95% CI: 1.04-6.80), any serious adverse event (OR 2.30, 95% CI: 1.18-4.48), serious a
4                                                             Serious adverse events (AEs) occurred in 10% of imipenem/rele
5  replacement (TPVR) is associated with a risk of procedural serious adverse events (SAE) and exposure to ionizing radiati
6 he end-of-treatment outcomes, culture-conversion rates, and serious adverse events (SAEs) during treatment.
7                                                             Serious adverse events occurred equally between groups.
8                                                    Nonfatal serious adverse events occurred in 12/72 (16.7%) in the oral
9 0), any serious adverse event (OR 2.30, 95% CI: 1.18-4.48), serious adverse events related to abnormal liver function tes
10                                                          No serious adverse events were attributed to dihydroartemisinin-
11                                                             Serious adverse events were more common with systematic treat
12                                                       Eight serious adverse events were reported with capsular release an
13                                         Cumulative rates of serious adverse events were similar in TAK-003 (4.0%) and pla
14 rmed COVID-19, and safety, as measured by the occurrence of serious adverse events.
15      There were no significant between-group differences in serious adverse events.
16 inferior to interventional management, with a lower risk of serious adverse events.
17                                                          17 serious adverse reactions occurred in 11 patients, and there
18                               Further, there were no ocular serious AEs (SAEs) and no cases of endophthalmitis.
19                Treatment was well tolerated in most however serious AEs can occur in those with advanced liver disease.
20 ions (LRs) and systemic events (SEs), adverse events (AEs), serious AEs, newly diagnosed chronic medical conditions, and
21 t be achieved without compromising hemostasis, thus causing serious bleeding and increased morbidity and mortality.
22            Together, these findings highlight a potentially serious confound in prior work, raising new theoretical and m
23                  Increasing air pollution in South Asia has serious consequences for air quality and human/ecosystem heal
24  believe that this work establishes organic polaritons as a serious contender to the well-established GaAs platform for a
25  suffering and improve the quality of life of children with serious disease and increase support for their parents and ot
26                 Severe acute malnutrition (SAM) is the most serious form of undernutrition, characterized by wasting with
27 f adipose tissue and liver are associated with a variety of serious health risks.
28 M17 JMD identified in a patient with Tetralogy of Fallot, a serious heart valve defect, affects the substrate selectivity
29                        Major depressive disorder (MDD) is a serious, heterogeneous disorder accompanied by brain-related
30 ril formation is central to the etiology of a wide range of serious human diseases, such as Alzheimer's disease and prion
31 pful guidance on how to have meaningful conversations about serious illness using telecommunication.
32 t needs to be properly evaluated as there can be underlying serious illnesses as in our patient.
33                                           Our findings have serious implications for the management of PCB contamination
34                Neutropenia and neutrophil dysfunction cause serious infections and inflammatory bowel disease in glycogen
35 nts with opioid use disorder (OUD) who are hospitalized for serious infections requiring prolonged intravenous antibiotic
36 up and six (1%) of 427 patients in the adalimumab group had serious infections.
37        Five (25%) patients under active treatment developed serious infectious events, and two (10%) developed diverticul
38 otica virgifera virgifera (Coleoptera: Chrysomelidae), is a serious insect pest in the major corn growing areas of North
39 ght in meters squared) of 40 or higher or 35 or higher with serious obesity-related comorbidities.
40                      Both SARS-CoV and MERS-CoV have caused serious outbreaks and epidemics in the past eighteen years.
41                                                             Serious procedure-related adverse events were uncommon.
42 e estimated daily intake calculation, samples do not pose a serious risk to public health.
43                                                This poses a serious roadblock for clinical translation of this approach.
44          The design was observational, 21 of 36 studies had serious ROB, and publication bias was possible.
45                 However, use of CsA is associated with more serious side effects and worse clinical outcomes than FK506.
46 n is effective when initiated early in illness but can have serious side effects.
47                                                   There are serious theoretical problems with the free-energy principle m
48                             These prime cases epitomize the serious threat that wildlife poisoning poses to biodiversity.
49 use of death globally, and drug-resistant TB strains pose a serious threat to controlling the global TB epidemic.
50                                 Enterovirus 71 (EV71) poses serious threats to human health, particularly in Southeast As